{
  "article": {
    "pmcid": "PMC4418487",
    "title": "Pirfenidone for idiopathic pulmonary fibrosis: systematic review",
    "journal": "Respiratory Medicine",
    "year": 2015,
    "key_findings": [
      "Pirfenidone reduced all-cause mortality by 48% versus placebo.",
      "Patients receiving pirfenidone maintained exercise capacity over 52 weeks.",
      "Adverse events were primarily gastrointestinal and manageable."
    ],
    "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418487/"
  }
}
